Finance

Lists
3750:TYO
ADR Biomedical Holdings Inc
788,00 JP¥
+0,90%
(+7,00) 1D
6 қаз., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 3750...
Open
778 JP¥
High
795 JP¥
Low
773 JP¥
Mkt. cap
7,04 млрд
Avg. vol.
8,93 мың
Volume
6,60 мың
52-wk high
890 JP¥
52-wk low
759 JP¥
EPS
-44 JP¥
Shares outstanding
6,71 млн
No. of employees
13
Open
778 JP¥
High
795 JP¥
Low
773 JP¥
Mkt. cap
7,04 млрд
Avg. vol.
8,93 мың
Volume
6,60 мың
52-wk high
890 JP¥
52-wk low
759 JP¥
EPS
-44 JP¥
Shares outstanding
6,71 млн
No. of employees
13
News stories
From web sources and news partners
About ADR Biomedical Holdings Inc
CEO-
Employees13
Founded2004 ж. 01 қаз.
Headquarters-
Sector-
Websiteadr.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
12,00 млн
15,00 млн
17,00 млн
57,00 млн
Cost of goods sold
9,00 млн
21,00 млн
8,00 млн
7,00 млн
Cost of revenue
9,00 млн
21,00 млн
8,00 млн
7,00 млн
Research and development expenses
89,00 млн
-89,00 млн
153,00 млн
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
114,00 млн
272,00 млн
65,00 млн
142,00 млн
Operating expense
203,00 млн
183,00 млн
395,00 млн
142,00 млн
Total operating expenses
212,00 млн
204,00 млн
403,00 млн
149,00 млн
Operating income
-200,00 млн
-189,00 млн
-386,00 млн
-92,00 млн
Other non operating income
1,00 млн
5,00 млн
-1,00 млн
-
EBT including unusual items
-199,00 млн
-185,00 млн
-79,00 млн
-93,00 млн
EBT excluding unusual items
-199,00 млн
-185,00 млн
-459,00 млн
-93,00 млн
Income tax expense
1,00 млн
-
1,00 млн
-
Effective tax rate
-0,50%
-
-1,27%
-
Other operating expenses
-
-
43,00 млн
-
Net income
-200,00 млн
-185,00 млн
-80,00 млн
-93,00 млн
Net profit margin
-1 666,67%
-1 233,33%
-470,59%
-163,16%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-1,00 млн
-70,00 млн
-
Net interest expenses
-
-1,00 млн
-70,00 млн
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-187,75 млн
-176,75 млн
-373,75 млн
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары